NCT07640893: A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease
- State
- Under way
- Phase
- Phase 2
- People
- 24 planned
- Started
- 26 Nov 2025
- Primary completion
- 31 Dec 2027
- Arms
- Multiple-dose exploratory efficacy trial consists of 4 cohorts
- Results
- None posted
- 26 Nov 2025: Trial started
- 11 Jun 2026: Trial registered